St. Paul, Minnesota, United States, October 2025 — Solventum (NYSE: SOLV) has announced the appointment of Heather Knight as Chief Commercial Officer, effective November 10, 2025. In this newly created role, Knight will oversee global commercial and R&D operations across Solventum’s MedSurg, Dental Solutions, and Health Information Systems segments, reporting directly to CEO Bryan Hanson.
With more than 30 years of leadership experience in the MedTech industry, Knight brings an extensive track record of driving operational excellence, innovation, and global growth. Most recently, she served as Chief Operating Officer at Baxter International, leading global sales across three business segments in addition to R&D, supply chain, and medical and regulatory affairs. Earlier in her career, Knight held senior leadership roles at Medtronic, Covidien, Tyco Healthcare, and Kendall, and currently serves on the Board of Directors of Waters Corporation.
“Heather’s appointment to the new role of Chief Commercial Officer reflects Solventum’s commitment to building a high-performing organization and progress to becoming a leading global MedTech company,” said Bryan Hanson, CEO of Solventum. “By aligning our go-to-market strategy under one leader, we will enhance our ability to leverage Solventum’s scale, drive coordinated execution, and achieve profitable growth. Heather’s deep sector experience and strategic vision will be instrumental as we execute our transformation as a standalone company.”
“I am thrilled to join Solventum at this pivotal time in the execution of the company’s multi-year strategic plan,” said Heather Knight. “Solventum has leading businesses with the right to win in their respective markets, and I look forward to strengthening commercial productivity and market development with our talented global team.”
As part of the transition, Chris Barry, Executive Vice President and Group President of MedSurg, will depart Solventum effective December 31, 2025.
“I want to thank Chris for his tremendous leadership and contributions to Solventum,” added Hanson. “He has played an important role in leading our largest business segment, and we are pleased he will stay with us through the remainder of the year to support a seamless transition.”
This leadership change will not impact Solventum’s financial guidance. The company will provide its next update in early November when reporting third-quarter results.
About Solventum
Solventum enables better, smarter, safer healthcare to improve lives. As a new company with a long legacy of breakthrough innovation, it pioneers game-changing solutions at the intersection of health, materials, and data science, improving patient outcomes while empowering healthcare professionals to perform at their best.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
